HomeCompareHOLX vs TU

HOLX vs TU: Dividend Comparison 2026

HOLX yields 2.65% · TU yields 9.45%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TU wins by $2.34M in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
TU
TU
● Live price
9.45%
Share price
$12.87
Annual div
$1.22
5Y div CAGR
44.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.36M
Annual income
$1,543,337.84
Full TU calculator →

Portfolio growth — HOLX vs TU

📍 TU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXTU
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + TU cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
TU pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
TU
Annual income on $10K today (after 15% tax)
$802.96/yr
After 10yr DRIP, annual income (after tax)
$1,311,837.16/yr
At 15% tax rate, TU beats the other by $1,311,570.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + TU for your $10,000?

HOLX: 50%TU: 50%
100% TU50/50100% HOLX
Portfolio after 10yr
$1.19M
Annual income
$771,825.93/yr
Blended yield
64.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HOLX right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
TU
Analyst Ratings
14
Buy
8
Hold
1
Sell
Consensus: Buy
Price Target
$22.59
+75.5% upside vs current
Range: $21.50 — $24.00
Altman Z
0.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
TU buys
0
No recent congressional trades found for HOLX or TU in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXTU
Forward yield2.65%9.45%
Annual dividend / share$2.00$1.22
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.4%
Portfolio after 10y$23.6K$2.36M
Annual income after 10y$314.03$1,543,337.84
Total dividends collected$2.9K$2.25M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusHoldBuy
Analyst price target$77.80$22.59

Year-by-year: HOLX vs TU ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrTU PortfolioTU Income/yrGap
1← crossover$10,965$264.73$12,064$1,364.09$1.1KTU
2$12,004$271.27$15,129$2,220.86$3.1KTU
3$13,121$277.55$19,947$3,758.66$6.8KTU
4$14,323$283.54$28,031$6,687.67$13.7KTU
5$15,615$289.27$42,676$12,682.89$27.1KTU
6$17,003$294.73$71,722$26,058.33$54.7KTU
7$18,493$299.93$135,844$59,101.12$117.4KTU
8$20,093$304.87$296,418$151,065.90$276.3KTU
9$21,809$309.57$762,020$444,852.69$740.2KTU
10$23,649$314.03$2,358,700$1,543,337.84$2.34MTU

HOLX vs TU: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

TUStock

TELUS Corporation, together with its subsidiaries, provides a range of telecommunications and information technology products and services in Canada. It operates through Technology Solutions and Digitally-Led Customer Experiences segments. The Technology Solutions segment offers a range of telecommunications products and services; network revenue; mobile technologies equipment sale; data revenues, such as internet protocol; television; hosting, managed information technology, and cloud-based services; software, data management, and data analytics-driven smart food-chain technologies; home and business security; healthcare software and technology solutions; and voice and other telecommunications services. The Digitally-Led Customer Experiences segment provides digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions. It has 16.9 million subscriber connections, which include 9.3 million mobile phone subscribers; 2.1 million connected device subscribers; 2.3 million internet subscribers; 1.1 million residential voice subscribers; 1.3 million TV subscribers; and 804,000 security subscribers. The company was formerly known as TELUS Communications Inc. and changed its name to TELUS Corporation in February 2005. TELUS Corporation was incorporated in 1998 and is headquartered in Vancouver, Canada.

Full TU Calculator →
📬

Get this HOLX vs TU comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.